InvestorsHub Logo
Followers 16
Posts 1898
Boards Moderated 0
Alias Born 05/12/2016

Re: joseytheoutlawwales post# 3482

Wednesday, 10/20/2021 2:21:51 PM

Wednesday, October 20, 2021 2:21:51 PM

Post# of 4271
Thanks again Josey. And my apologies if you feel you are caught in any crossfire conversations.

My hometown provides an Overdose Kit in a zipper pouch for addicts to keep with them. In the event of an OD, they are most likely too incapacitated to administer to themselves but anyone nearby can follow the printed instructions to attempt to revive them. I do not know what form the meds are in those kits.

Given their existing Symjepi product, I would see no reason they shouldn't quickly apply a similar packaging solution to the ZIMHI product as well.

I'm glad you share our optimism for the usefulness of the newly approved product and for the future of our investments.


Message in reply to:
66, the more I read about ZIMHi overall, I truly believe they will develop an auto-injector, similar to an epipen.

This is designed for a layperson to use, in addition to prehospital(ems/fire/pd) and hospital staff.

The higher dose of ZIMHi is specifically created to combat the Fentanyl surge. As I’ve been out of the loop, so to speak, I’m guessing that Narcan nasal alone hasn’t been sufficient in competing with fentanyl, and thus the higher blood concentration of Narcan in ZIMHi will likely allow for improved patient resuscitation numbers.

Given the fentanyl epidemic, I would think this will end up being added to treatment algorithms nationwide.

Ignore the stock price, and manipulation. The science works, and the FDA just confirmed it. Ignore the noise.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADMP News